{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T22:57:44Z","timestamp":1793487464479,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.bcmd.2010.08.003","type":"journal-article","created":{"date-parts":[[2010,9,2]],"date-time":"2010-09-02T04:55:41Z","timestamp":1283403341000},"page":"293-296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["The relation of C-reactive protein to vasoocclusive crisis in children with sickle cell disease"],"prefix":"10.1016","volume":"45","author":[{"given":"Fatima A.","family":"Mohammed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najat","family":"Mahdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai A.","family":"Sater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadija","family":"Al-Ola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wassim Y.","family":"Almawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2010.08.003_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/03630260802625709","article-title":"Newer aspects of the pathophysiology of sickle cell disease vaso-occlusion","volume":"33","author":"Conran","year":"2009","journal-title":"Hemoglobin"},{"key":"10.1016\/j.bcmd.2010.08.003_bb0010","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2174\/0929867013373778","article-title":"Sickle cell anemia and antisickling agents then and now","volume":"8","author":"Mehanna","year":"2001","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bcmd.2010.08.003_bb0015","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1182\/asheducation-2004.1.35","article-title":"Sickle cell disease, hematology","author":"Buchanan","year":"2004","journal-title":"Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.bcmd.2010.08.003_bb0020","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0140-6736(04)17192-4","article-title":"Sickle-cell disease","volume":"364","author":"Stuart","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.bcmd.2010.08.003_bb0025","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1172\/JCI30920","article-title":"Sickle cell disease: old discoveries, new concepts, and future promise","volume":"117","author":"Frenette","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcmd.2010.08.003_bb0030","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/10739680802279394","article-title":"Sickle red cell\u2013endothelium interactions","volume":"16","author":"Kaul","year":"2009","journal-title":"Microcirculation"},{"key":"10.1016\/j.bcmd.2010.08.003_bb0035","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1182\/blood-2008-01-134346","article-title":"Sickle red cells induce adhesion of lymphocytes and monocytes to endothelium","volume":"112","author":"Zennadi","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2010.08.003_bb0040","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1182\/blood-2002-10-3313","article-title":"Transgenic sickle mice have vascular inflammation","volume":"101","author":"Belcher","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2010.08.003_bb0045","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1189\/jlb.0708445","article-title":"Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy","volume":"85","author":"Lanaro","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bcmd.2010.08.003_bb0050","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1172\/JCI10726","article-title":"Sickle cell anemia as an inflammatory disease","volume":"106","author":"Platt","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcmd.2010.08.003_bb0055","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1365-2141.2009.08013.x","article-title":"Increased levels of the inflammatory biomarker C-reactive protein at baseline are associated with childhood sickle cell vasocclusive crises","volume":"148","author":"Krishnan","year":"2010","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2010.08.003_bb0060","first-page":"337","article-title":"Is C-reactive protein a marker of inflammation?","volume":"24","author":"Dupuy","year":"2003","journal-title":"Nephrologie"},{"issue":"Suppl A","key":"10.1016\/j.bcmd.2010.08.003_bb0065","first-page":"41A","article-title":"C-reactive protein: risk factor, biomarker and\/or therapeutic target?","volume":"26","author":"Genest","year":"2010","journal-title":"Can. J. Cardiol."},{"issue":"Suppl 1","key":"10.1016\/j.bcmd.2010.08.003_bb0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2165\/1153161-S0-000000000-00000","article-title":"Markers of inflammation and cardiovascular disease: clinical applications of C-reactive protein determination","volume":"9","author":"Mart\u00ednez","year":"2009","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.bcmd.2010.08.003_bb0075","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/clinchem\/43.1.52","article-title":"Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications","volume":"43","author":"Macy","year":"1997","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bcmd.2010.08.003_bb0080","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1172\/JCI200318921","article-title":"C-reactive protein: a critical update","volume":"111","author":"Pepys","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcmd.2010.08.003_bb0085","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1203\/pdr.0b013e31802d7754","article-title":"Energy expenditure, inflammation, and oxidative stress in steady-state adolescents with sickle cell anemia","volume":"61","author":"Akohoue","year":"2007","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.bcmd.2010.08.003_bb0090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1600-0609.1998.tb01060.x","article-title":"Acute phase proteins and interleukins in steady state sickle cell disease","volume":"61","author":"Bourantas","year":"1998","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.bcmd.2010.08.003_bb0095","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/10245330310001604719","article-title":"Cytokines in sickle cell disease","volume":"8","author":"Pathare","year":"2003","journal-title":"Hematology"},{"key":"10.1016\/j.bcmd.2010.08.003_bb0100","first-page":"282","article-title":"Clinical value of C-reactive protein, alpha 1-glycoprotein acid and transferrin assay in homozygous sickle cell disease","volume":"86","author":"Monnet","year":"1993","journal-title":"Bull. Soc. Pathol. Exot."},{"key":"10.1016\/j.bcmd.2010.08.003_bb0105","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/ajh.2830460108","article-title":"Enhancement of pain control with ketorolac tromethamine in patients with sickle cell vaso-occlusive crisis","volume":"46","author":"Perlin","year":"1994","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2010.08.003_bb0110","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0140-6736(93)90418-G","article-title":"Is there an acute-phase response in steady-state sickle cell disease?","volume":"341","author":"Singhal","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.bcmd.2010.08.003_bb0115","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1001\/archinte.166.3.366","article-title":"C-reactive protein and vascular cell adhesion molecule-1 as markers of severity in sickle cell disease","volume":"166","author":"Makis","year":"2006","journal-title":"Arch. Int. Med."},{"key":"10.1016\/j.bcmd.2010.08.003_bb0120","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/01.mbc.0000164431.98169.8f","article-title":"Plasma levels of tissue factor and soluble E-selectin in sickle cell disease: relationship to genotype and to inflammation","volume":"16","author":"Mohan","year":"2005","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.bcmd.2010.08.003_bb0125","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/jcp.47.2.166","article-title":"Monitoring the acute phase response to vaso-occlusive crisis in sickle cell disease","volume":"47","author":"Stuart","year":"1994","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.bcmd.2010.08.003_bb0130","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1749-6632.2000.tb06201.x","article-title":"Reactive species in sickle cell disease","volume":"899","author":"Aslan","year":"2000","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.bcmd.2010.08.003_bb0135","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1136\/jcp.45.10.902","article-title":"Subclinical ischaemic episodes during the steady state of sickle cell anaemia","volume":"45","author":"Akinola","year":"1992","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.bcmd.2010.08.003_bb0140","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2796.1993.tb01000.x","article-title":"Acute phase reactants and severity of homozygous sickle cell disease","volume":"233","author":"Hedo","year":"1993","journal-title":"J. Intern. Med."},{"issue":"Suppl 1","key":"10.1016\/j.bcmd.2010.08.003_bb0145","first-page":"S63","article-title":"Serum C-reactive protein level in postsplenectomized thalassemic patients","volume":"83","author":"Archararit","year":"2000","journal-title":"J. Med. Assoc. Thai."},{"key":"10.1016\/j.bcmd.2010.08.003_bb0150","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bcmd.2009.06.002","article-title":"Soluble endothelial adhesion molecules and inflammation markers in patients with beta-thalassemia intermedia","volume":"43","author":"Kanavaki","year":"2009","journal-title":"Blood Cells Mol. Dis."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979610002019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979610002019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:27:17Z","timestamp":1761049637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979610002019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S1079979610002019"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2010.08.003","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relation of C-reactive protein to vasoocclusive crisis in children with sickle cell disease","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2010.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}